TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Inovent AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
176
|
198
|
204 |
Financial expenses |
4
|
3
|
2 |
Earnings before taxes |
6
|
19
|
4 |
Total assets |
161
|
192
|
121 |
Current assets |
106
|
114
|
106 |
Current liabilities |
11
|
13
|
16 |
Equity capital |
100
|
103
|
84 |
- share capital |
9
|
10
![]() |
10 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
62.1%
|
53.6%
|
69.4% |
Turnover per employee |
88
|
99
|
102 |
Profit as a percentage of turnover |
3.4%
|
9.6%
|
2.0% |
Return on assets (ROA) |
6.2%
|
11.5%
|
5.0% |
Current ratio |
963.6%
|
876.9%
|
662.5% |
Return on equity (ROE) |
6.0%
|
18.4%
|
4.8% |
Change turnover |
-11
|
-17
|
8 |
Change turnover % |
-6%
|
-8%
|
4% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.